Once cautious, OpenAI, Grok, and others will now dive into giving unverified medical advice with virtually no disclaimers.

As Microsoft, Intel, and Google lean into AI-driven restructuring, workers face shrinking salaries, fewer entry-level roles, ...

The Food and Drug Administration has granted permission for Juul to continue selling its e-cigarettes, offering some reprieve ...

Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

For Stephen Yeager, who owns a Theodore company that helps lawyers with digital forensics, research and jury consulting, artificial intelligence has been a “game-changer.” But there are potential ...

The UK now has one of the most energy-efficient supercomputers in the world, with the unveiling of the new Isambard-AI ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

However, ChatGPT, Copilot, Deepseek and Meta AI failed to mention that if you enroll in a Medicare Advantage plan and later want to switch to original Medicare, you can be rejected for a Medigap plan ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Daniel Nadler started OpenEvidence to help physicians sort through a deluge of medical research. Now, he’s raised $210 ...